Pelthos Therapeutics Inc: director Pauls Matthew sold 786 shares

What happened Pauls Matthew, a director, sold 786 shares at $21.00 per share on Oct 02, 2026, for $16,506. The Form 4 reports the disposition as a sale (code S).

Key details

• Transaction date and price: Oct 02, 2026 — 786 shares at $21.00 per share.
• Shares owned after the transaction: not provided in the filing excerpt supplied.
• Footnote: the filing states the sale was made pursuant to a Rule 10b5-1 plan adopted Dec 16, 2025, to satisfy estimated tax obligations in connection with the vesting of restricted stock units granted by the issuer (footnote F1).
• Filing date: filed with the SEC on Oct 06, 2026; the supplied information does not indicate a late filing.

Why it may matter

• This was a market sale executed under a Rule 10b5-1 plan for tax withholding related to vested restricted stock units, per the filing.
• This filing does not show why the insider traded or why the company acted.